| Wykrzykowska, Joanna J |
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation |
|
|
| Recruiting | 4 | 3010 | Europe | P2Y12 inhibitor, Aspirin, DOAC | Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited | Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor | 09/26 | 12/26 | | |
NCT04703699: Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis. |
|
|
| Recruiting | N/A | 200 | Europe, RoW | Myval Transcatheter Heart Valve Series, Myval THV | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 05/24 | 11/28 | | |
| Active, not recruiting | N/A | 418 | Europe, Canada, US, RoW | SELUTION SLR™ DEB, Control | M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation | Coronary Restenosis | 07/25 | 08/29 | | |
| Recruiting | N/A | 768 | Europe, RoW | Myval THV Series, Myval/Myval Inception THVs or any subsequent advanced version commercially available at the study site., Contemporary Valves (Sapien THV Series and Evolut THV Series), Sapien THV Series (Sapien 3/Sapien 3 Ultra THVs) and Evolut THV Series (Evolut R/Evolut PRO THVs ) or any subsequent advanced version commercially available at the study site. | Meril Life Sciences Pvt. Ltd. | Aortic Valve Stenosis | 03/24 | 12/33 | | |
| Active, not recruiting | N/A | 466 | Europe | No PCI | UMC Utrecht, ZonMw: The Netherlands Organisation for Health Research and Development | Valvular Heart Disease, Aortic Valve Stenosis, Coronary Artery Disease | 12/25 | 12/29 | | |
| Active, not recruiting | N/A | 3326 | Europe, RoW | SELUTION SLR, DES | M.A. Med Alliance S.A. | Coronary Artery Disease | 08/25 | 07/30 | | |
PROVE, NCT05539573: ACURATE neo2™ - Post Market Safety and Performance Surveillance in Aortic Stenosis |
|
|
| Active, not recruiting | N/A | 1043 | Europe | Planned TAVI with the ACURATE neo2™ aortic bioprosthesis and ACURATE neo2™ transfemoral delivery system. | University of Leipzig, National University of Ireland, Galway | Aortic Stenosis | 04/25 | 04/25 | | |
PIONEER-IV, NCT04923191: The Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent |
|
|
| Recruiting | N/A | 2540 | Europe | Angiography-derived physiology guidance/Local routine diagnostic procedure (LRDP) and usual care | National University of Ireland, Galway, Ireland | Coronary Artery Disease | 01/26 | 01/29 | | |
| Recruiting | N/A | 650 | Europe, Canada, Japan, US, RoW | Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT) | Medtronic Cardiovascular | Moderate Aortic Valve Stenosis | 02/26 | 12/34 | | |
